Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T1GT
|
|||
Former ID |
DAP001201
|
|||
Drug Name |
Sulfacytine
|
|||
Synonyms |
Renoquid; Sulfacitina; Sulfacitine; Sulfacitinum; CL 636; Renoquid (TN); Sulfacitina [INN-Spanish]; Sulfacitinum [INN-Latin]; Sulfacytine (USAN); Sulfacytine [USAN:BAN]; N-Sulfanilyl-l-ethylcytosine; Nl-sulfanilyl-1-ethylcytosine; N(sup 1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide; N(sup1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide; Sulfanilamide, N1-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-(8CI); 1-Ethyl N4-sulfanilylcytosin; 1-Ethyl-N-sulfanilylcytosine; 4-amino-N-(1-ethyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzenesulfonamide; 4-amino-N-(1-ethyl-2-oxopyrimidin-4-yl)benzenesulfonamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cystitis [ICD-11: GC00] | Approved | [1], [2] | |
Urinary tract infection [ICD-11: GC08; ICD-10: N39, N39.0] | Approved | [1], [2] | ||
Therapeutic Class |
Antiinfective Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H14N4O3S
|
|||
Canonical SMILES |
CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N
|
|||
InChI |
1S/C12H14N4O3S/c1-2-16-8-7-11(14-12(16)17)15-20(18,19)10-5-3-9(13)4-6-10/h3-8H,2,13H2,1H3,(H,14,15,17)
|
|||
InChIKey |
SIBQAECNSSQUOD-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 17784-12-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:135230
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bacterial Dihydropteroate synthetase (Bact folP) | Target Info | Inhibitor | [3] |
References | Top | |||
---|---|---|---|---|
REF 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 017569. | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 3 | Sulfacytine in uncomplicated urinary tract infections. Double-blind comparison with sulfisoxazole. Urology. 1976 Mar;7(3):267-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.